Products
16931 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Motors Constant Leverage with ISIN code: CH1450970228 | General Motors | Constant Leverage | Long | ― | 87.167 | 3.89 | 0.040 | 3.93 | 1 | -7.82% | 21.94% | 14.08% | 3 Nov. 2025 | |
| General Motors Constant Leverage with ISIN code: CH1423416242 | General Motors | Constant Leverage | Long | ― | 87.167 | 32.65 | 0.310 | 32.96 | 1 | -6.29% | 16.77% | 15.33% | 7 May. 2025 | |
| General Motors Constant Leverage with ISIN code: CH1199369534 | General Motors | Constant Leverage | Long | ― | 87.167 | 1.9 | 0.020 | 1.92 | 1 | -5.47% | 13.10% | 13.77% | 24 Jun. 2022 | |
| General Motors Constant Leverage with ISIN code: CH1235293201 | General Motors | Constant Leverage | Long | ― | 87.167 | 0.32 | 0.010 | 0.33 | 1 | -8.57% | 14.29% | 10.34% | 30 Nov. 2022 | |
| General Motors Constant Leverage with ISIN code: CH1119067788 | General Motors | Constant Leverage | Long | ― | 87.167 | 2.96 | 0.020 | 2.98 | 1 | -3.90% | 10.86% | 12.98% | 11 May. 2022 | |
| Genmab Constant Leverage with ISIN code: CH1119068364 | Genmab | Constant Leverage | Long | ― | 2,105.101 | 0.39 | 0.010 | 0.4 | 1 | -9.30% | -7.14% | 34.48% | 18 May. 2022 | |
| Genmab Constant Leverage with ISIN code: CH1235293474 | Genmab | Constant Leverage | Long | ― | 2,105.101 | 0.14 | 0.010 | 0.15 | 1 | -12.50% | -12.50% | 40.00% | 10 Jan. 2023 | |
| Genmab Constant Leverage with ISIN code: CH1450969170 | Genmab | Constant Leverage | Long | ― | 2,105.101 | 10.17 | 0.070 | 10.24 | 1 | -7.55% | -7.12% | 63.50% | 21 Aug. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1450969451 | Genmab | Constant Leverage | Long | ― | 2,105.101 | 4.5 | 0.030 | 4.53 | 1 | -7.41% | -7.02% | 63.04% | 15 Sep. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1423417562 | Genmab | Constant Leverage | Long | ― | 2,105.101 | 1.36 | 0.010 | 1.37 | 1 | -9.93% | -9.33% | 83.78% | 13 Jun. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1119068372 | Genmab | Constant Leverage | Short | ― | 2,105.101 | 0.18 | 0.010 | 0.19 | 1 | -5.26% | -5.26% | -43.75% | 18 May. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223048 | Gilead Sciences | Constant Leverage | Long | ― | 145.769 | 7.42 | 0.020 | 7.44 | 1 | -1.59% | 24.92% | 74.18% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223055 | Gilead Sciences | Constant Leverage | Long | ― | 145.769 | 0.42 | 0.010 | 0.43 | 1 | -4.55% | 27.27% | 90.91% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1119067762 | Gilead Sciences | Constant Leverage | Long | ― | 145.769 | 24.98 | 0.050 | 25.03 | 1 | -1.11% | 17.06% | 48.51% | 11 May. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968131 | Gilead Sciences | Constant Leverage | Short | ― | 145.769 | 0.21 | 0.010 | 0.22 | 1 | 0.00% | -32.26% | -59.62% | 9 Jul. 2025 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968149 | Gilead Sciences | Constant Leverage | Short | ― | 145.769 | 1.1 | 0.010 | 1.11 | 1 | 0.92% | -21.43% | -43.30% | 9 Jul. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1450971911 | Givaudan | Constant Leverage | Long | ― | 3,310.039 | 17.4 | 0.310 | 17.71 | 1 | 8.41% | 53.17% | 13.36% | 5 Jun. 2026 | |
| Givaudan Constant Leverage with ISIN code: CH1119066574 | Givaudan | Constant Leverage | Long | ― | 3,310.039 | 1.23 | 0.010 | 1.24 | 1 | 4.24% | 17.14% | 10.81% | 27 Apr. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1450971903 | Givaudan | Constant Leverage | Long | ― | 3,310.039 | 18.72 | 0.270 | 18.99 | 1 | 6.79% | 32.48% | 14.15% | 5 Jun. 2026 | |
| Givaudan Constant Leverage with ISIN code: CH1450971929 | Givaudan | Constant Leverage | Long | ― | 3,310.039 | 14.77 | 0.380 | 15.15 | 1 | 8.84% | 68.03% | 9.65% | 5 Jun. 2026 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.